| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| ATC: | V03AB32 |
| UNII: | GAN16C9B8O |
| InChI Key | RWSXRVCMGQZWBV-WDSKDSINSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C10H17N3O6S |
| Molecular Weight | 307.33 |
| AlogP | -2.21 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 6.0 |
| Number of Rotational Bond | 9.0 |
| Polar Surface Area | 158.82 |
| Molecular species | ZWITTERION |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 20.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Transferase
|
- | 20 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 67 | |
|
Transporter
Primary active transporter
ATP-binding cassette
ABCC subfamily
|
- | - | - | - | 10 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Peripheral Nervous System Diseases | 3 | D010523 | ClinicalTrials |
| Peripheral Nervous System Diseases | 3 | D010523 | ClinicalTrials |
| Pain | 3 | D010146 | ClinicalTrials |
| Cystic Fibrosis | 3 | D003550 | ClinicalTrials |
| Parkinson Disease | 2 | D010300 | ClinicalTrials |
| Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
| Reperfusion Injury | 2 | D015427 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Persian Gulf Syndrome | 1 | D018923 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 70-18-8 |
| ChEBI | 16856 |
| ChEMBL | CHEMBL1543 |
| DrugBank | DB00143 |
| DrugCentral | 1312 |
| EPA CompTox | DTXSID6023101 |
| FDA SRS | GAN16C9B8O |
| Human Metabolome Database | HMDB0000125 |
| Guide to Pharmacology | 6737 |
| KEGG | C02471 |
| PDB | GSH |
| PubChem | 124886 |
| SureChEMBL | SCHEMBL9167 |
| ZINC | ZINC000003830891 |